🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
An outstanding scientific question, that merits further investigation, is w...
Status
Completed
Location
Danish Headache Center
Start Date
2023-04-20
Trial ID
NCT05889455
Treatments Being Tested
The proposed study is a retrospective, non-interventional analysis that use...
Status
Completed
Location
Novartis Investigative Site
Start Date
2020-08-31
Trial ID
NCT05177406
Treatments Being Tested
A pharmacokinetic drug interaction study of erenumab and an oral contracept...
Status
Completed
Location
Research Site
Start Date
2016-02-12
Trial ID
NCT02792517
Treatments Being Tested
Evaluate erenumab- aooe efficacy as a therapeutic approach, for the managem...
Status
Terminated
Location
University of Maryland, School of Dentistry, Brotman Facial Pain Clinic
Start Date
2022-05-26
Trial ID
NCT05162027
Treatments Being Tested
A randomized, double-blind, placebo-controlled, parallel study to investiga...
Status
Unknown
Location
Danish Headache Center
Start Date
2020-07-22
Trial ID
NCT04452929
Treatments Being Tested
This is a placebo-controlled, multi-arm phase II platform screening trial d...
Status
Recruiting
Location
Massachusetts General Hospital Cancer Center
Start Date
2023-08-31
Trial ID
NCT05684692
Treatments Being Tested
This study is a single center, placebo-controlled, double blind, randomized...
Status
Terminated
Location
University of Maryland, School of Dentistry, Brotman Facial Pain Clinic
Start Date
2022-05-31
Trial ID
NCT05142228
Treatments Being Tested
The primary purpose of this study is to determine whether erenumab is safe ...
Status
Completed
Location
Research Site
Start Date
2012-03-13
Trial ID
NCT01688739
The primary objective of the study was to evaluate the effect of erenumab c...
Status
Completed
Location
Research Site
Start Date
2015-07-17
Trial ID
NCT02456740
Study 20170703 is a phase 4, randomized, double-blind, parallel-group, plac...
Status
Completed
Location
Core Healthcare Group
Start Date
2019-10-07
Trial ID
NCT03971071
Treatments Being Tested